
GAMP5 Software Validation
Intrinsic Imaging is a GAMP5-compliant imaging core lab. We implemented ISPE’s risk-based framework in March 2012 and apply its principles to computerized systems supporting clinical image management and radiological review. The purpose is practical: establish that a system is fit for its intended use and maintain control as the system and its use change.
Intrinsic Imaging’s validation approach connects the study’s imaging requirements with its configured workflow. Participant and visit identifiers, reader permissions, assessment forms, measurement rules and data-transfer specifications determine how information moves from an acquired image to a delivered result. Software validation addresses whether the systems supporting that work perform their defined functions and preserve reliable electronic records.
For a trial sponsor, the benefit is not a claim that software cannot fail. It is a disciplined basis for evaluating system suitability, addressing risks to trial data and maintaining confidence in the records used to interpret study results.
Intrinsic Imaging’s March 2012 GAMP 5 implementation announcement records the adoption of this framework across our organization.
GAMP 5: A Framework for Systems Fit for Intended Use
GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems is published by the International Society for Pharmaceutical Engineering (ISPE). It provides guidance for managing computerized systems used in regulated life-science activities, including clinical research. The framework combines process understanding, lifecycle management and quality risk management rather than prescribing identical testing for every system.
ISPE’s second edition, published in 2022, retains five key concepts and places renewed emphasis on critical thinking. Validation effort should reflect intended use, complexity and the consequences of failure. Supplier knowledge and existing evidence can contribute to the assessment, while the regulated organization remains responsible for the suitability of its own use.
Understand the Clinical Imaging Process
GAMP 5 starts with product and process understanding. Intrinsic Imaging defines study workflows from the protocol, imaging charter and transfer requirements. This gives system use a clinical context: the correct participant, visit, assessment method, reader role and output.
Manage the System Throughout Its Lifecycle
GAMP 5 connects concept, project, operation and retirement within a quality management system. Intrinsic Imaging’s organization-wide implementation places software validation alongside controlled configuration, operating procedures, change control and record retention—not only an initial software test.
Scale Activities to the System
GAMP 5 calls for activities proportionate to system complexity and intended use. A configured reading workflow and a custom calculation may need different evidence. The relevant question is whether verification adequately addresses the function and its risk, not whether every application has the same document count.
Direct Effort Toward Meaningful Risks
GAMP 5 uses science-based quality risk management to prioritize patient safety, product quality and data integrity. For trial imaging, risks include incorrect record associations, inappropriate reader visibility and changes to assessment or transfer rules. These consequences give verification its priorities.
Use Supplier Knowledge Appropriately
GAMP 5 encourages effective use of supplier involvement and evidence. Supplier documentation can inform qualification and avoid unnecessary duplication. It still needs to be considered against the configured workflow, interfaces and responsibilities of the organization using the system.
How Intrinsic Imaging Applies the Framework
Intrinsic Imaging configures visits, assessment forms, review sequences and adjudication rules around the study’s imaging charter. Study-specific roles and visibility rules support independent blinded review. Validation connects these settings to intended use so that a software product’s general capabilities are not mistaken for evidence that a particular study configuration is suitable.
Intrinsic Imaging reconciles identifiers, image records, assessments and released results across the workflow. Transfer specifications define content, units and precision. These are consequential details: a correct measurement associated with the wrong visit, or delivered with the wrong unit, can misrepresent the study record. Risk-based verification focuses attention on the functions that preserve those relationships.
Intrinsic Imaging’s technology practices also include audit trails, controlled change, recovery testing and record retention. GAMP 5’s lifecycle approach gives these activities a common purpose: maintain the connection between the system’s current use and the evidence supporting that use. Changes need an impact assessment; the extent of additional verification follows the affected functions and risks.
Our clinical imaging technology workflows connect these responsibilities from study configuration and image intake through independent review, data delivery and retention.
Traceable System Evidence
The Evidence Behind a Validated Imaging Workflow
Validation connects what a system must do with objective evidence that it performs as intended. Risk assessment directs the depth of verification; controlled change preserves that evidence over time.
Intended Use & Requirements
Define the imaging process, critical functions and acceptance criteria.
Risk Assessment
Prioritize participant protection, blinding and data integrity.
Controlled Configuration
Establish the study settings, access roles and approved baseline.
Verification Evidence
Link functional tests and end-to-end workflow checks to the requirements they verify.
Review & Approved Release
Assess results and deviations against acceptance criteria before release.
Maintain the Validated State
Training, change assessment and periodic review keep evidence connected to use.
What GAMP5 Compliance Contributes to a Trial
Intrinsic Imaging’s GAMP5 approach supports the integrity of the imaging evidence a trial generates. Defined workflows and controlled records help preserve the relationship between source images, reader assessments and delivered data. Appropriate access and review sequencing support the independence of central reads, while reconciliation helps identify inconsistencies before results are released.
Sponsors also gain a more substantive basis for oversight. Intended use, configuration, risk decisions and supporting verification are the relevant subjects for qualification and audit discussions. Continued change control and retention practices help keep that assessment meaningful after study start-up, through amendments, system updates and eventual close-out.
GAMP 5 and Clinical Electronic-Record Requirements
GAMP5 compliance describes Intrinsic Imaging’s application of ISPE’s guidance; it is not a GAMP certification or a regulatory approval. Applicable clinical-investigation regulations determine which records must be maintained. Where electronic records or signatures fall within its scope, 21 CFR Part 11 adds requirements for their control. GAMP 5 provides a risk-based way to organize the work needed to address those obligations.
FDA’s guidance on electronic systems, records and signatures in clinical investigations supports risk-based validation informed by intended use and the potential effect on participant protection and trial results. Validation of trial infrastructure is distinct from establishing the clinical performance of an investigational AI algorithm or medical device. Reliable study systems support that evaluation; they do not replace it.
Intrinsic Imaging supports AI/CAD clinical validation studies and medical device imaging trials with controlled imaging workflows. Our FDA inspection history and ISO-certified quality framework are separate from the evidence that establishes a particular system’s fitness for use.
Frequently Asked Questions
Must I complete a form to download Intrinsic Imaging’s PDFs?
When should a sponsor consider transferring a study to Intrinsic Imaging?
Who interprets musculoskeletal images at Intrinsic Imaging?
Discuss Your Trial’s Imaging Systems
Contact Intrinsic Imaging about your study’s imaging workflow, system qualification and validation considerations.